Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma

Gene Therapy

Volumn 6, Issue 4, 1999, Pages 465-470

  Ishikawa, H ^a   Nakata, K ^a   Mawatari, F ^a   Ueki, T ^a   Tsuruta, S ^a   Ido, A ^b   Nakao, K ^c   Kato, Y ^a   Ishii, N ^c   Eguchi, K ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

fetoprotein; Gene therapy; Hepatocellular carcinoma; Thymidine kinase

Indexed keywords

ALPHA FETOPROTEIN; GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL GROWTH; CONTROLLED STUDY; DNA TRANSFECTION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RETROVIRUS;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; POINT MUTATION; PROMOTER REGIONS (GENETICS); RETROVIRIDAE; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

HERPES; UNIDENTIFIED RETROVIRUS;

EID: 0032959142     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300870     Document Type: Article

References (33)

1. Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. New Engl J Med 1995; 332: 1294-1296.
2. Sato Y et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. New Engl J Med 1993; 328: 1802-1806.
3. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-287.
4. Huber BE, Richards CA, Krenitsky TA. Retrovirus-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991; 88: 8039-8043.
5. Ido A et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res 1995; 55: 3105-3109.
6. Kuriyama S et al. Tissue-specific expression of HSVtk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma. Int J Cancer 1997; 71: 470-475.
7. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
8. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
9. Paul S, Dummer S. Topics in clinical pharmacology: ganciclovir. Am J Med Sci 1992; 304: 272-277.
10. McVey JH et al. A G→A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP). Hum Mol Genet 1993; 2: 379-384.
11. Freeman SM et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
12. Alpert ME, Uriel J, Nechaud Bd. Alpha-1 fetoglobulin in the diagnosis of human hepatoma. New Engl J Med 1968; 278: 984-986.
13. Hatano M et al. Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells. Biochem Biophys Res Commun 1992; 189: 385-391.
14. Mitsuoka S et al. Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells. Prostaglandins 1992; 43: 189-197.
15. Nakao K et al. Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells. Biochem Biophys Res Commun 1991; 174: 1294-1299.
16. Nakata K et al. A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester. J Biol Chem 1992; 267: 1331-1334.
17. Tsutsumi T et al. Regulation of albumin and alpha-fetoprotein gene expression by colloid osmotic pressure in human hepatoma cells. Gastroenterology 1993; 104: 256-262.
18. Nakabayashi H et al. A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol 1991; 11: 5885-5893.
19. Vacher J, Tilghman SM. Dominant negative regulation of the mouse alpha-fetoprotein gene in adult liver. Science 1990; 250: 1732-1735.
20. Nahon JL et al. The rat alpha-fetoprotein and albumin genes. Transcriptional control and comparison of the sequence organization and promoter region. J Biol Chem 1987; 262: 12479-12487.
21. Sawadaishi K, Morinaga T, Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes. Mol Cell Biol 1988; 8: 5179-5187.
22. Bois-Joyeux B, Danan JL. Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha- fetoprotein promoter and enhancer. Biochem J 1994; 301: 49-55.
23. Otsuru A et al. Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization. Cancer 1988; 62: 1105-1112.
24. Ng IO et al. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994; 73: 2268-2274.
25. Mawatari F et al. Retrovirus-mediated gene therapy for hepato-cellular carcinoma: selective and enhanced suicide gene expression regulated by human a-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 1998; 5: 301-306.
26. Ueki T et al. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice. Int J Mol Med 1998; 1: 671-675.
27. Kanai F et al. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 1996; 23: 1359-1368.
28. Wills KN et al. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther 1995; 2: 191-197.
29. Nakabayashi H et al. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-3863.
30. Nakabayashi H et al. Phenotypical stability of a human hepatoma cell line, HuH- 7, in long-term culture with chemically defined medium. Gann 1984; 75: 151-158.
31. Tsutsumi T et al. Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells. Gastroenterology 1994; 107: 499-504.
32. Felgner PL et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
33. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044-1051.